Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Clinical trial NCT03190941 · RECRUITING
Trial details
- NCT number
- NCT03190941
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2027-06-29
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.